Skip to main content

Digital Diabetes Management Market: Medtronic plc (Ireland) and Roche Diagnostics (Switzerland) Key Market Players

Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel) are the leading players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, approvals, and enhancements; expansions; agreements, collaborations, and partnerships; and mergers & acquisitions.

The global digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%. Factors such as the rising prevalence of diabetes, technological advancements, increasing adoption of cloud-based enterprise solutions, and the growing use of connected devices and apps are driving the growth of this market. However, high device costs and lack of reimbursement in developing countries and the higher acceptance of traditional diabetes management devices are expected to restrain the growth of this market during the forecast period.

Roche Diagnostics accounted for the second-largest share of the digital diabetes management market in 2018. The company offers connected glucose meters, CGM systems, smart insulin pens, smart insulin pumps, smart insulin patches, and data management software. Under its flagship brand Accu-Check, Roche offers a variety of digital diabetes management devices and software platforms that are widely used by end users across the globe. Roche also has a wide geographic presence spanning North America, Europe, the Middle East & Africa, and the Asia Pacific.

Know more: https://tinyurl.com/y3dvtb9y 

To improve patient experience, the company focuses on growth strategies, such as collaborations, partnerships, agreements, and acquisitions. Additionally, it also focuses on enhancing and launching products to strengthen its product portfolio. For instance, in June 2018, the company launched the Sugar.IQ smart diabetes assistant app for the management of diabetes patients. 

Visit: https://www.marketsandmarkets.com/Market-Reports/digital-diabetes-management-market-144725893.html

Comments

Popular posts from this blog

Smoke Evacuation Systems Market: Renewed Growth Opportunities Owing to the Increasing Number of Elective Procedures

  Which are The Key Factors Driving Growth in Smoke Evacuation System Market? Factors such increased product availability of smoke evacuation systems, rising patient preference for minimally invasive surgeries, expansion in the target patient population, and wider acceptance and availability of relevant operating room protocols and guidelines for smoke evacuation systems are the major factors driving the growth of the global smoke evacuation system market. How The Smoke Evacuation Industry Will Grow in Coming Years? The surgical smoke evacuation system market is estimated to grow at a CAGR of 6.6% to reach USD 154 million by 2025 from USD 115 million in 2020. Emerging countries and increasing number of elective surgical procedures. Emerging countries (such as China, India, South Korea, Brazil, and Mexico) offer significant growth opportunities to players operating in the global smoke evacuation systems market. This can be attributed to the increasing public and private i...

Illumina (US), Thermo Fisher (US), and QIAGEN (Netherlands)—Major Players in the Global Epigenetics Market

The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2017, at a CAGR of 13.5% from 2017 to 2022. Favorable government funding initiatives for epigenetics research, increasing research activities, decreasing sequencing costs & time, and rising prevalence of cancer are the key factors driving market growth Key players in the global epigenetics market, such as Illumina, Thermo Fisher, Diagenode, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, and PerkinElmer, are focusing on increasing their presence in the high-growth markets through organic as well as inorganic strategies such as product launches, partnerships, agreements, collaborations, expansions, and acquisitions. http://www.marketsandmarkets.com/ResearchInsight/epigenetics-technologies-market.asp Illumina dominated the global epigenetics market in 2016. The company provides sequencing and array-based solutions for ge...

Best Accounting Software to Kick-start the Business for Smaller Firms – Xero

  Xero Accounting Software is an online software mainly designed for the accounting needs of small business firms. The software can be operated from a PC, phone, tablet, or Mac to view the cash flows of the company in real-time. The software is for small business houses and hence it is simple to use yet smart so that the users can devote most of the time in other important areas of their business. USP of This Software: Xero accounting software offers accounting services to small business firms in a smarter way. Some of the USPs of the software the more than 800apps integrated into the software, secure encryption, support system better performance report generation, and others apart from the basic accounting services offered. Best Accounting Software for Medium-Sized Businesses@ https://blog.360quadrants.com/2020/best-accounting-software-for-medium-sized-businesses/ Xero Pricing Xero accounting software offers 30 days of free trial after which you can choose from any of the pri...